semaglutide europe Novo Nordisk's Ozempic faces EU review for potential eye disease connection European Medicines Agency to investigate

Structure of the human cationchloride cotransporter NKCC1 determined by single-particle electron cryo-microscopy

Potter SR, Horniger W, Tinzl M, Bartsch G, Partin AW

113 Similarly, small extracellular vesicles carrying CAR mRNA have been demonstrated to activate local immunity or generate CAR effector cells in situ within lung cancer models, thereby strengthening the tumor immune microenvironment

The submissions are for generic forms of semaglutide, the active ingredient in Novo Nordisk's injectable drugs Ozempic and Wegovy, the former approved by Health Canada for diabetes and the latter for weight loss

Both are small, both have fine needles, both measure in increments